Moderna Inc

Healthcare · Biotechnology

194.80$ +7.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 10,961 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRNA
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,417	6.1	6.6	6.2	1,084	1,602	1,602	1,489	1,962	1,806	1,685	1,591	1,589	2,068	3,486	4,651	7,337	12,694	16,153	20,923	24,669	27,609	26,043	26,056	25,858	24,125	21,884	19,450	18,426	16,729	15,680	15,803	14,142	12,704	12,010	12,135	12,338	11,488	10,961
Current Assets	1,087	1,058	0.4	0.1	783	756	1,163	1,118	1,563	1,547	1,435	1,094	1,129	1,250	2,797	3,577	6,298	11,703	10,969	13,425	16,071	16,350	13,563	14,297	13,431	12,122	10,599	10,799	10,325	9,600	9,661	9,666	8,099	6,766	6,171	6,598	6,544	5,770	5,815
Cash	50	-1,058	0.3	0.0	135	-756	141	167	658	503	152	174	236	392	1,762	1,506	2,624	5,442	5,603	5,550	6,848	5,048	2,873	3,027	3,205	3,441	3,801	2,932	2,907	2,051	2,478	1,644	1,927	1,623	1,279	1,132	2,595	1,908	1,723
Cash & Short-Term Investments	–	1,058	–	–	756	756	1,115	1,072	1,694	1,547	1,435	1,059	1,103	1,218	2,717	3,276	4,608	7,735	7,990	8,906	10,727	10,115	7,897	8,348	9,902	8,923	8,459	7,573	8,604	8,523	8,488	6,867	7,025	5,975	5,131	4,505	5,799	5,205	5,138
Receivables	18	–	–	–	18	19	12	12	31	24	18	25	16	19	58	213	1,408	3,228	2,071	3,199	3,323	3,364	2,844	2,821	1,685	1,521	688	2,146	1,081	387	423	1,836	592	306	457	1,394	284	147	103
Inventory	–	–	–	–	–	–	0.0	0.8	-173	-32	-27	–	-26	–	-355	-692	47	494	643	965	1,441	1,942	1,921	2,077	949	732	715	487	202	295	399	412	117	128	240	332	153	146	280
Property, Plant & Equipment	81	–	–	–	139	202	202	206	212	213	209	204	288	303	322	369	387	461	898	960	1,383	1,473	1,446	2,132	2,139	–	2,410	2,717	–	–	–	–	–	–	–	–	–	–	–
Goodwill	3.6	3.5	3.5	3.5	3.5	3.5	3.5	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	52	52	52	52	52	52	52	52	52	52	52	52	52	52
Intangible Assets	2.3	2.2	2.7	2.7	2.6	2.4	2.3	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	48	46	45	44	43	42	41	40	49	48	47	45	116	109
Total Liabilities	575	2.7	4.2	4.6	459	453	453	413	432	360	347	339	415	427	539	1,891	4,776	8,856	9,449	10,799	10,524	10,534	8,058	8,064	6,735	5,262	4,935	5,995	4,572	3,912	3,968	3,876	3,241	2,638	2,611	2,805	3,688	4,080	4,200
Current Liabilities	163	2.7	4.2	4.6	191	200	200	186	223	159	162	148	143	135	162	1,474	4,389	8,441	8,840	9,957	9,128	9,238	6,812	6,807	4,923	3,499	3,123	4,385	3,015	2,380	2,363	2,201	2,206	1,604	1,572	1,681	1,987	2,395	2,534
Short-Term Debt	0.7	0.9	1.5	1.5	73	2.1	–	45	79	42	45	60	68	55	89	4.7	30	52	170	240	211	206	159	260	196	181	221	183	25	25	25	51	37	43	43	48	–	50	52
Accounts Payable	28	0.6	0.9	1.0	21	28	28	24	31	39	30	12	7.1	11	19	21	18	8.0	77	87	302	199	181	330	487	389	310	494	520	183	279	373	405	226	175	267	317	161	167
Long-Term Debt	13	–	–	–	16	27	27	27	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	590	590	591
Shareholders' Equity	842	842	2.5	1.6	625	625	1,149	1,076	1,530	1,446	1,339	1,252	1,175	1,641	2,947	2,760	2,561	3,838	6,704	10,124	14,145	17,075	17,985	17,992	19,123	18,863	16,949	13,455	13,854	12,817	11,712	11,927	10,901	10,066	9,399	9,330	8,650	7,408	6,761
Retained Earnings	-366	-3.0	-4.2	-5.2	-622	-785	-785	-874	-1,007	-1,111	-1,246	-1,370	-1,496	-1,621	-1,737	-1,971	-2,244	-1,023	1,757	5,090	9,958	13,615	15,812	16,855	18,320	18,399	17,019	13,389	13,606	12,431	11,152	11,165	10,045	9,074	8,249	8,049	7,223	5,880	5,098
Shares Outstanding	–	64	64	65	297	395	395	324	329	329	329	331	334	353	381	395	397	430	431	434	431	426	419	412	405	405	381	381	395	382	384	399	385	386	388	390	392	395	396

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings